Dexcom, Inc. share price logo

Dexcom, Inc. Share Price

NASDAQ: DXCM

Large Cap

$77.00

+1.42

(+1.88%)

Live

as on

Dexcom, Inc. Stock Performance

as on September 17, 2025 at 12:36 am IST

  • Day's Low

    Day's High

    $75.64
    $77.73
    downward going graph

    1.77%

    Downside

    0.95%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $57.52
    $93.25
    downward going graph

    25.30%

    Downside

    21.10%

    Upside

    downward going graph

Dexcom, Inc. share price movements today

Previous Close
$75.58
Open
$75.79
Volume
2.0M
Day's Low - High
$75.64 - $77.73
52 Week Low - High
$57.52 - $93.25

Dexcom, Inc. Historical Returns

1 Month Return
-6.63 %
3 Month Return
-8.94 %
1 Year Return
+ 7.83 %
3 Year Return
-16.11 %
5 Year Return
-23.25 %

Dexcom, Inc. Stock Fundamentals & Key Indicators

Check Dexcom, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$29.9B

EPS (TTM)

2.0503

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.27%

PE Ratio (TTM)

53.6

Industry PE ratio

16.65525641025641

P/B Ratio

53.6028

PEG Ratio

0.9712

EBITDA

923.3M

Revenue (TTM)

4.3B

Profit Margin

13.29%

Return On Equity TTM

22.83%

Dexcom, Inc. Stock Valuation

Track how Dexcom, Inc. P/E has moved over time to understand its valuation trends.

Dexcom, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (44.87x)

December 31, 2024

Industry (16.66x)

September 16, 2025

Today (53.60x)

September 16, 2025

Highest (175.15x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 53.60x

Dexcom, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dexcom, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$29.9B-23.25%53.613.29%
BUY$152.2B148.49%60.913.55%
BUY$146.6B74.74%50.7612.25%
BUY$232.8B24.25%16.7732.43%
BUY$120.6B-13.08%25.9513.63%

Stock Returns calculator for Dexcom, Inc. Stock including INR - Dollar returns

The Dexcom, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dexcom, Inc. investment value today

Current value as on today

₹1,14,726

Returns

₹14,726

(+14.73%)

Returns from Dexcom, Inc. Stock

₹9,859 (+9.86%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Dexcom, Inc. Stock

Based on 30 analysts

BUY

86.67%

Buy

13.33%

Hold

0.00%

Sell

Based on 30 analysts, 86.67% of analysts recommend a 'BUY' rating for Dexcom, Inc.. Average target price of $102.08

Dexcom, Inc. Share Price Target

Get share price movements and forecasts by analysts on Dexcom, Inc..

What analysts predicted

24.57%UPSIDE

Target Price

$102.08

Current Price

$77

Analyzed by

30 Analysts

Target

$102.08

Dexcom, Inc. target price $102.08, a slight upside of 24.57% compared to current price of $77. According to 30 analysts rating.

Dexcom, Inc. Stock's Interest Amongst Investors

Investment in Dexcom, Inc. Shares on INDmoney has grown by 108.33% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:108.33% versus previous 30 day period

Search interest for Dexcom, Inc. Stock has increased by 173% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:173% versus previous 30 day period

Dexcom, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
741
871
975
1,034
921
1,004
994
1,113
1,036
1,157
Gross Profit
462
546
623
656
561
626
593
655
589
688
Operating Income
47
128
205
216
101
158
152
188
133
212
EBITDA
110
208
293
303
189
244
237
274
219
308
Interest Expense
4
5
4
4
4
4
4
4
4
4
Depreciation
41
1
1
52
52
52
55
57
60
63
Income Before Tax
64
159
240
246
132
187
177
211
154
241
Income Tax Expense
15
43
119
-10
-13
44
42
59
48
61
Net Income
48
115
120
256
146
143
134
151
105
179
Net Profit Margin
6.55%
13.30%
12.38%
24.78%
15.90%
14.29%
13.54%
13.62%
10.17%
15.54%

Dexcom, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
402
573
718
1,031
1,476
1,926
2,448
2,909
3,622
4,033
Gross Profit
278
378
492
663
931
1,280
1,680
1,883
2,288
2,438
Operating Income
-57
-63
-42
-186
142
299
265
391
597
600
EBITDA
-46
-49
-19
-74
213
376
377
565
916
945
Interest Expense
0
0
12
22
60
84
18
18
20
19
Depreciation
-
-
16
29
48
67
102
155
186
217
Income Before Tax
-57
-64
-48
-126
104
225
256
390
710
709
Income Tax Expense
0
0
1
0
3
-268
39
49
168
132
Net Income
-57
-65
-50
-127
101
493
216
341
541
576
Net Profit Margin
-14.33%
-11.44%
-6.99%
-12.32%
6.85%
25.62%
8.86%
11.73%
14.95%
14.29%

Dexcom, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
115
120
256
146
143
134
151
105
179
Operating Cash Flow
190
269
133
209
279
199
301
183
303
Investing Cash Flow
-555
-179
414
74
-188
210
-303
100
-63
Financing Cash Flow
939
-637
-631
4
-1
-736
-1
12
-1
Change in Cash
571
-551
-77
284
88
-316
-15
298
254

Dexcom, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-65
-50
-127
101
493
154
341
541
576
Operating Cash Flow
56
92
123
314
475
442
669
748
989
Investing Cash Flow
-55
-144
-139
-1,015
-1,018
-216
-521
-507
-207
Financing Cash Flow
8
399
710
10
912
10
-552
-318
-734
Change in Cash
8
347
695
-690
371
235
-410
-75
39

Global Institutional Holdings in Dexcom, Inc.

Funds
Holdings
Vanguard Group Inc
12.1%
BlackRock Inc
10.01%
Baillie Gifford & Co Limited.
4.26%
State Street Corp
4.25%
Capital Research Global Investors
3.07%

Dexcom, Inc. News & Key Events

  • img

    Today's Timeline - 15 September

    Mon, 12:46 PM

    -

    Dexcom announces new features and data on glucose biosensing at EASD 2025, highlighting improved health outcomes and cost-effectiveness.

Insights on Dexcom, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Dexcom, Inc. has shown strong profit growth over the last two quarters. The company's net profit increased from $105.4 million to $179.8 million, representing an average quarterly growth of 41.4%. This positive trend indicates that the company's profitability has been consistently improving.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Dexcom, Inc. has shown positive revenue growth over the last two quarters. The revenue increased from $1.03 billion to $1.15 billion, marking an average growth of 10.5% each quarter.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Boston Scientific Corp. has given 19.6% return, outperforming this stock by 11.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Boston Scientific Corp. has given 139.5% return, outperforming this stock by 155.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, DXCM stock has moved down by -3.6%

About Dexcom, Inc.

founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.
OrganisationDexcom, Inc.
Headquarters6340 Sequence Drive, San Diego, CA, United States, 92121
IndustryHealth Technology
CEOMr. Kevin Ronald Sayer
E-voting on sharesClick here to vote

Key Management of Dexcom, Inc.

Name

Title

Mr. Kevin Ronald Sayer

Executive Chairman & CEO

Mr. Michael Jon Brown

Executive VP & Chief Legal Officer

Mr. Sean Christensen

Vice President of Finance and Investor Relations

Mr. Matthew Dolan

Executive Vice President of Strategy & Corporate Development

Mr. Donald M. Abbey

Executive Vice President of Global Business Services, IT, Quality & Regulatory Affairs

Mr. Jacob Steven Leach

President & COO

Mr. Jereme M. Sylvain CPA

Executive VP, CFO & Chief Accounting Officer

Ms. Sadie M. Stern

Executive VP & Chief Human Resources Officer

Mr. Girish Naganathan

Executive VP & CTO

Ms. Leverne Marsh

Executive Vice President of Marketing

FAQs

What is Dexcom, Inc. share price today?

Dexcom, Inc. share price today is $77 as on . Dexcom, Inc. share today touched a day high of $77.73 and a low of $75.64.

What is the 52 week high and 52 week low for Dexcom, Inc. share?

Dexcom, Inc. share touched a 52 week high of $93.25 on and a 52 week low of $57.52 on . Dexcom, Inc. stock price today i.e. is trending at $77,which is 17.43% down from its 52 week high and 33.87% up from its 52 week low.

What is Dexcom, Inc.'s market capitalisation today?

Dexcom, Inc. market capitalisation is $0.03T as on .

How to invest in Dexcom, Inc. Stock (DXCM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dexcom, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dexcom, Inc. Shares that will get you 0.0195 shares as per Dexcom, Inc. share price of $77 per share as on September 17, 2025 at 12:36 am IST.

What is the minimum amount required to buy Dexcom, Inc. Stock (DXCM) from India?

Indian investors can start investing in Dexcom, Inc. (DXCM) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Dexcom, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Dexcom, Inc. share’s latest price of $77 as on September 17, 2025 at 12:36 am IST, you will get 0.1299 shares of Dexcom, Inc.. Learn more about fractional shares .

What are the returns that Dexcom, Inc. has given to Indian investors in the last 5 years?

Dexcom, Inc. stock has given -23.25% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?